Skip to content

High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter

High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05777850
Acronym
FASD-HP
Enrollment
120
Registered
2023-03-21
Start date
2022-10-25
Completion date
2025-04-30
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Ablation, Typical Atrial Flutter

Keywords

Typical Atrial Flutter Cavotricuspid Isthmus, Cavotricuspid Isthmus, High-Power Short-Duration

Brief summary

The aim of cavotricuspid isthmus (CTI) dependent flutter ablation is the bidirectional conduction block of CTI. The probability of achieving a permanent bidirectional block at the CTI depends, mainly, on the ablation energy applied and the quality of the obtained lesion. Among the factors that determine the lesion's quality those which have the bigger impact are catheter stability, contact force, power and duration of energy application and the temperature reached at depth.This is a multicenter 1:1 randomized, blinded (open for the operator) study. Two CTI ablation strategies are compared: 1) conventional treatment branch which consists of individual 25-40 W applications of unlimited duration until achieving in each application the minimum value of one of the currently accepted and used lesion markers (Ablation Index \>500 at the anterior half of the CTI and \>400 at the posterior half with de CARTO 3 system; 2) experimental treatment branch consistent of CTI block using individual high power (90W) short duration (4 seconds) point-by-point applications. The main objective of this study is assessing the non-inferiority of the efficacy and safety of high-power short-duration ablation in patients undergoing typical atrial flutter ablation. Secondary objectives include the comparison of total radiofrequency time, number of applications, number of steam pops, percentage of reconnections, procedure duration, pain during the procedure and time to atrial flutter recurrence.

Interventions

PROCEDUREConventional cavotricuspid isthmus ablation

Point-by-point 25-40 W applications at the CTI of unlimited duration until achieving the pre-established Ablation Index.

PROCEDUREHigh-power short-duration ablation

Point-by-point 90W applications at the CTI ablation during 4 seconds.

Sponsors

Jose Luis Ibañez Criado
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with cavotricuspid isthmus dependent flutter referred to ablation * Patients clinically and hemodynamically stable. * Patients who give informed consent.

Exclusion criteria

* Refusal to participate in the register or inability to understand the informed consent. * Age under 18. * Patients who have already undergone previous flutter ablation procedures.

Design outcomes

Primary

MeasureTime frameDescription
Safety primary outcome: incidence of procedure-related complications.One yearNumber of procedure-related complications from the time of the ablation until the last follow-up visit.
Efficacy primary outcome: typical atrial flutter recurrence.One yearIncidence of typical atrial flutter recurrence during a one-year follow-up period. To be considered clinically relevant the recurrence must be documented by a full EKG made because of patients' symptoms or any typical atrial flutter detected by an EKG, 24h Holter-EKG or events-monitoring device that will be performed at least at a 6 months and 12 months follow-up visits.

Countries

Spain

Contacts

Primary ContactLaura Valverde Soria
lauravalverdesoria@gmail.com687198597

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026